Sign in
Stories
Assertio Holdings Faces Investor Lawsuit
Share
Assertio Acquires Spectrum Pharmaceutica...
Assertio Holdings Faces Securities Law I...
Assertio Holdings Faces Securities Lawsu...
Altimmune Faces Investor Investigation
Assertio Faces Lawsuit Amid Stock Declin...
Assertio Holdings Faces Securities Lawsu...
Overview
API
Investors reminded of class action deadline against Assertio Holdings, Inc. due to alleged misleading statements and stock declines.
Ask a question
How does the FDA approval of generic versions of pharmaceutical products typically impact the stock prices of the original manufacturers?
How might the outcome of the class action lawsuit affect Assertio Holdings' future operations and reputation?
What measures could companies like Assertio take to ensure transparency and accuracy in their communications with investors?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage